NCT00426036View on ClinicalTrials.gov

Effect of Severe Renal Impairment on Pharmacokinetics and Metabolism of a Single Administration of Licarbazepine

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

June 30, 2006

Conditions
Healthy
Interventions
DRUG

Licarbazepine

Trial Locations (1)

Unknown

Novartis Investigative site, Prague

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY

NCT00426036 - Effect of Severe Renal Impairment on Pharmacokinetics and Metabolism of a Single Administration of Licarbazepine | Biotech Hunter | Biotech Hunter